Psoriasis

Although psoriasis is associated with an increased risk of premature death, little is known about the factors that contribute to this risk. In a recent study, researchers aimed to assess the effects of...

To determine the safety and efficacy of tildrakizumab, researchers conducted 2 phrase 3 trials with over 1800 patients with moderate-to-severe plaque psoriasis.

No previous studies have directly compared the effects of hidradenitis suppurativa and psoriasis on health-related quality of life.

In a recent study, researchers used data from the 2013 US National Health and Wellness Survey to assess the health-related quality of life and productivity among adults with atopic dermatitis and psoriasis...

After clinical trials demonstrated its efficacy, the US Food and Drug Administration approved a biologic therapy for the treatment of patients with moderate to severe plaque psoriasis.

A recent study assessed whether or not psoriasis and psoriatic arthritis are associated with osteoporosis and related conditions.

A study sought to test the belief that women are less likely to experience severe psoriasis than men.

A recent study examined the association between depression and the risk of developing psoriatic arthritis in patients with psoriasis.

The FDA approved the injection Siliq (brodalumab) to treat adults with moderate to severe plaque psoriasis.

A new study examined the long-term effects of weight loss on the severity of psoriasis in participants.